Center For Financial Planning, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Center For Financial Planning, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $573 - $724	-1 Reduced 9.09%	10 $7,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $5,483 - $7,388	10 Added 1000.0%	11 $7,000
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $543 - $670	1 New	1 $1,000
Q2 2020 Aug 06, 2020	SELL	$493.32 - $643.92 $4,933 - $6,439	-10 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $3,361 - $4,944	10 New	10 $5,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Center For Financial Planning, Inc. with notifications on news.